Page last updated: 2024-08-23

bromocriptine and Hyperlipidemias

bromocriptine has been researched along with Hyperlipidemias in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Kawakami, K; Matsubayashi, K1
Christensen, NC; Hagen, C; Nielsen, MD; Petersen, S1
Cvak, L; Golda, V1
Cincotta, AH; Liang, Y; Lubkin, M; Scislowski, PW; Sheng, H1
Cincotta, AH; Phaneuf, S; Prevelige, R; Scislowski, PW; Zhang, Y1

Other Studies

5 other study(ies) available for bromocriptine and Hyperlipidemias

ArticleYear
Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database.
    Endocrine journal, 2020, Oct-28, Volume: 67, Issue:10

    Topics: Acromegaly; Adenoma; Adult; Aged; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Comorbidity; Dopamine Agonists; Female; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Hyperlipidemias; Hypertension; Incidence; Japan; Male; Middle Aged; Neurosurgical Procedures; Octreotide; Peptides, Cyclic; Prevalence; Radiosurgery; Radiotherapy, Intensity-Modulated; Retrospective Studies; Somatostatin; Young Adult

2020
Hypernatraemia, diabetes mellitus, hyperprolactinaemia, retarded growth and delayed puberty in a 14 year old girl. Effect of bromocriptine treatment.
    Acta endocrinologica, 1981, Volume: 96, Issue:1

    Topics: Adolescent; Bromocriptine; Diabetes Mellitus, Type 1; Estradiol; Female; Gonadotropins, Pituitary; Growth Disorders; Humans; Hydrocortisone; Hyperlipidemias; Hypernatremia; Pituitary Function Tests; Prolactin; Puberty, Delayed; Renin

1981
Terguride but not bromocriptine alleviated glucose tolerance abnormalities and hyperlipidaemia in obese and lean genetically hypertensive Koletsky rats.
    Physiological research, 1994, Volume: 43, Issue:5

    Topics: Animals; Blood Pressure; Body Weight; Bromocriptine; Disease Models, Animal; Female; Glucose Intolerance; Hyperlipidemias; Hypertension; Insulin; Lipids; Lisuride; Male; Obesity; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Sex Factors

1994
Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
    Biochimica et biophysica acta, 1998, Oct-21, Volume: 1405, Issue:1-3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Blood Glucose; Bromocriptine; Colforsin; Cyclic AMP; Dopamine Agonists; Glucokinase; Glucose; Hexokinase; Hyperglycemia; Hyperlipidemias; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Lipids; Mice; Mice, Inbred C57BL; Mice, Obese; Protein Kinase C; Tetradecanoylphorbol Acetate

1998
Bromocriptine/SKF38393 treatment ameliorates dyslipidemia in ob/ob mice.
    Metabolism: clinical and experimental, 1999, Volume: 48, Issue:8

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adipose Tissue; Animals; Bromocriptine; Dopamine Agonists; Drug Synergism; Drug Therapy, Combination; Female; Hyperlipidemias; Lipolysis; Lipoproteins; Mice; Mice, Obese; Receptors, Dopamine; Triglycerides

1999